This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (405)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46101, first published .
Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial

Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial

Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial

Authors of this article:

Zheyi Dong1, 2, 3, 4, 5 Author Orcid Image ;   Jianhui Zhou1, 2, 3, 4, 5 Author Orcid Image ;   Zhonggao Xu6 Author Orcid Image ;   Zhaohui Ni7 Author Orcid Image ;   Yani He8 Author Orcid Image ;   Hongli Lin9, 10 Author Orcid Image ;   Gengru Jiang11 Author Orcid Image ;   Xuefeng Sun1, 2, 3, 4, 5 Author Orcid Image ;   Li Zhang1, 2, 3, 4, 5 Author Orcid Image ;   Xiangmei Chen1, 2, 3, 4, 5 Author Orcid Image
Article Authors Cited by (1) Tweetations (3) Metrics

Journals

  1. Flores G, Cusumano G, Zengin G, Venanzoni R, Angelini P. Fungal Biomolecules for Food and Pharmaceutical Application. eFood 2025;6(1) View